-
-
-
-
-
-
-
Eisai, Biogen (BIIB) Announce U.S. FDA Grants Breakthrough Therapy Designation For Lecanemab (BAN2401), An Anti-Amyloid Beta Protofibril Antibody For The Treatment Of Alzheimer's Disease
-
67,170 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

